FeesSafety
Pluang+

AtlasClear expands correspondent clearing with eighth broker-dealer deal, boosting revenue potential.

Market News
02 Nov 2026, 23:37 WIB
GlobeNewsWire
View Source
Bullish
AtlasClear expands correspondent clearing with eighth broker-dealer deal, boosting revenue potential.

AtlasClear Holdings has signed its eighth correspondent broker-dealer agreement through its subsidiary AtlasClearing, expanding its clearing network from one to eight partners. This growth reflects rising demand from smaller broker-dealers for AtlasClear's clearing platform and is expected to increase clearing fees, stock loan income, and interest income as new partners onboard. The company reported strong fiscal 2026 results with an 85% revenue increase to $20.1 million, driven by stock locate revenue and interest income, before contributions from the new agreements. AtlasClear aims to leverage this expanded network to support its broader strategic initiatives, including acquisitions and banking services, positioning itself as a vertically integrated financial services platform.

AtlasClear Holdings' expansion of its correspondent clearing network to eight partners provides context for readers following financial services developments. For readers following the Financials sector, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: out of 142 priced US Financials-sector stocks tradable on Pluang, 83 rose and 59 fell. Notable movers include GEMI at USD 2.87 with a 1-day change of -6.82% and 100% sell order activity, WULF at USD 10.96 with a 1-day change of -6.56% and 100% buy order activity, and BAM at USD 51.39 with a 1-day change of +6.49%.

More News

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
13 minutes ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
13 minutes ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
2 hours ago
Amazon's AWS backlog hits $580B as it targets $1T revenue, despite heavy AI investment concerns.

Amazon's AWS backlog hits $580B as it targets $1T revenue, despite heavy AI investment concerns.

Amazon.com is reinforcing its market position with AWS backlog surging to $580 billion and aiming for a $1 trillion revenue run rate. Despite concerns over aggressive AI-related capital expenditures and delayed free cash flow recovery, management jus...

Market News
Bullish
5 hours ago
Exosens reports total shares and voting rights as of October 31, 2026, confirming capital structure details.

Exosens reports total shares and voting rights as of October 31, 2026, confirming capital structure details.

Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App